Trials / Unknown
UnknownNCT00867971
Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Assaf-Harofeh Medical Center · Other Government
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Measuring intraoccular pressure | Measurement of intraoccular pressure by tonometry |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-03-24
- Last updated
- 2009-03-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00867971. Inclusion in this directory is not an endorsement.